Nirman Agri Genetics Ltd.

As of September 30, 2025, Nirman Agri Genetics Ltd. carries a market capitalization of 1.43B, placing it among publicly traded companies globally. Its enterprise value stands at 1.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2025, Nirman Agri Genetics Ltd. has 8.01M shares outstanding.

These figures are as of September 30, 2025.

As of September 30, 2025, Nirman Agri Genetics Ltd. maintains a current ratio of 53.66, meaning it holds 53.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended September 30, 2025, Nirman Agri Genetics Ltd. recorded 5.93M in income tax expense.

As of the close on October 23, 2026, Nirman Agri Genetics Ltd.'s stock has declined approximately 82.38% over the past 52 weeks. The 50-day moving average sits at 27.96, while the 200-day moving average is 43.68.

As of September 30, 2025, Nirman Agri Genetics Ltd. holds 13.45M in cash and equivalents against 3.42M in total debt, resulting in a net debt position of -10.03M. Total book value stands at 1.25B, with working capital of 1.13B providing operational flexibility.